Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Heparan Sulfate Proteoglycans Retain Noggin at the Cell
Surface
A POTENTIAL MECHANISM FOR SHAPING BONE MORPHOGENETIC PROTEIN
GRADIENTS*
Stephenie
Paine-Saunders,
Beth L.
Viviano,
Aris N.
Economides§, and
Scott
Saunders¶
From the Department of Pediatrics, Washington
University School of Medicine and St. Louis Children's Hospital,
St. Louis, Missouri 63110, § Regeneron Pharmaceutical, Inc.,
Tarrytown, New York 10591, ¶ Department of Molecular Biology
and Pharmacology, Washington University School of Medicine,
St. Louis, Missouri 63110
Bone morphogenetic proteins (BMPs) are expressed
broadly and regulate a diverse array of developmental events in
vivo. Essentialto many of these functions is the establishment
of activity gradientsof BMP, which provide positional information that
influences cellfates. Secreted polypeptides, such as Noggin, bind BMPs
and inhibittheir function by preventing interaction with receptors on
thecell surface. These BMP antagonists are assumed to be diffusibleand therefore potentially important in the establishment of BMPactivity gradients in vivo. Nothing is known, however,
about thepotential interactions between Noggin and components of the
cellsurface or extracellular matrix that might limit its diffusion.We
have found that Noggin binds strongly to heparin in vitro,and to heparan sulfate proteoglycans on the surface of culturedcells.
Noggin is detected only on the surface of cells that expressheparan
sulfate, can be specifically displaced from cells by heparin,and can
be directly cross-linked to a cell surface proteoglycanin culture.
Heparan sulfate-bound Noggin remains functional andcan bind BMP4 at
the plasma membrane. A Noggin mutant with a deletionin a putative
heparin binding domain has reduced binding to heparinand does not bind
to the cell surface but has preserved BMP bindingand antagonist
functions. Our results imply that interactionsbetween Noggin and
heparan sulfate proteoglycans in vivo regulatediffusion
and therefore the formation of gradients of BMPactivity.
Seth S. Blair (25 September 2001) Sci. STKE2001 (101), pe32.
[DOI: 10.1126/scisignal.1012001pe32] |Abstract »|Full Text »|PDF »
PERSPECTIVES
Alfonso Martinez Arias (1 August 2000) Sci. STKE2000 (43), pe1.
[DOI: 10.1126/scisignal.432000pe1] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
An inwardly rectifying K+ channel is required for patterning.
G. R. Dahal, J. Rawson, B. Gassaway, B. Kwok, Y. Tong, L. J. Ptacek, and E. Bates (2012)
Development
139, 3653-3664
|Abstract »|Full Text »|PDF »
Heparan Sulfate Acts as a Bone Morphogenetic Protein Coreceptor by Facilitating Ligand-induced Receptor Hetero-oligomerization.
W.-J. Kuo, M. A. Digman, and A. D. Lander (2010)
Mol. Biol. Cell
21, 4028-4041
|Abstract »|Full Text »|PDF »
Conditional Ablation of the Heparan Sulfate-synthesizing Enzyme Ext1 Leads to Dysregulation of Bone Morphogenic Protein Signaling and Severe Skeletal Defects.
Y. Matsumoto, K. Matsumoto, F. Irie, J.-i. Fukushi, W. B. Stallcup, and Y. Yamaguchi (2010)
J. Biol. Chem.
285, 19227-19234
|Abstract »|Full Text »|PDF »
Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways.
S. Otsuki, S. R. Hanson, S. Miyaki, S. P. Grogan, M. Kinoshita, H. Asahara, C.-H. Wong, and M. K. Lotz (2010)
PNAS
107, 10202-10207
|Abstract »|Full Text »|PDF »
C. M. Vezina, H. A. Hardin, R. W. Moore, S. H. Allgeier, and R. E. Peterson (2010)
Toxicol. Sci.
113, 198-206
|Abstract »|Full Text »|PDF »
The extracellular regulation of bone morphogenetic protein signaling.
D. Umulis, M. B. O'Connor, and S. S. Blair (2009)
Development
136, 3715-3728
|Abstract »|Full Text »|PDF »
In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate.
R. G. Thorne, A. Lakkaraju, E. Rodriguez-Boulan, and C. Nicholson (2008)
PNAS
105, 8416-8421
|Abstract »|Full Text »|PDF »
Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity.
S. A. Khan, M. S. Nelson, C. Pan, P. M. Gaffney, and P. Gupta (2008)
Am J Physiol Cell Physiol
294, C1387-C1397
|Abstract »|Full Text »|PDF »
Noggin Suppression Enhances in Vitro Osteogenesis and Accelerates in Vivo Bone Formation.
D. C. Wan, J. H. Pomerantz, L. J. Brunet, J.-B. Kim, Y.-F. Chou, B. M. Wu, R. Harland, H. M. Blau, and M. T. Longaker (2007)
J. Biol. Chem.
282, 26450-26459
|Abstract »|Full Text »|PDF »
Mutational Analysis of Norrin-Frizzled4 Recognition.
P. M. Smallwood, J. Williams, Q. Xu, D. J. Leahy, and J. Nathans (2007)
J. Biol. Chem.
282, 4057-4068
|Abstract »|Full Text »|PDF »
X. Jiao, P. C. Billings, M. P. O'Connell, F. S. Kaplan, E. M. Shore, and D. L. Glaser (2007)
J. Biol. Chem.
282, 1080-1086
|Abstract »|Full Text »|PDF »
A {beta}1,4-galactosyltransferase is required for Bmp2-dependent patterning of the dorsoventral axis during zebrafish embryogenesis.
Q. J. Machingo, A. Fritz, and B. D. Shur (2006)
Development
133, 2233-2241
|Abstract »|Full Text »|PDF »
Crossveinless 2 is an essential positive feedback regulator of Bmp signaling during zebrafish gastrulation.
F. Rentzsch, J. Zhang, C. Kramer, W. Sebald, and M. Hammerschmidt (2006)
Development
133, 801-811
|Abstract »|Full Text »|PDF »
Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of Chordin.
R. Jasuja, B. L. Allen, W. N. Pappano, A. C. Rapraeger, and D. S. Greenspan (2004)
J. Biol. Chem.
279, 51289-51297
|Abstract »|Full Text »|PDF »
FGF-10 induces SP-C and Bmp4 and regulates proximal-distal patterning in embryonic tracheal epithelium.
B. A. Hyatt, X. Shangguan, and J. M. Shannon (2004)
Am J Physiol Lung Cell Mol Physiol
287, L1116-L1126
|Abstract »|Full Text »|PDF »
Bone Morphogenetic Protein (BMP)-6 Signaling and BMP Antagonist Noggin in Prostate Cancer.
D. R. Haudenschild, S. M. Palmer, T. A. Moseley, Z. You, and A. H. Reddi (2004)
Cancer Res.
64, 8276-8284
|Abstract »|Full Text »|PDF »
Branching morphogenesis and kidney disease.
M. M. Shah, R. V. Sampogna, H. Sakurai, K. T. Bush, and S. K. Nigam (2004)
Development
131, 1449-1462
|Abstract »|Full Text »|PDF »
Adenovirally Expressed Noggin and Brain-Derived Neurotrophic Factor Cooperate to Induce New Medium Spiny Neurons from Resident Progenitor Cells in the Adult Striatal Ventricular Zone.
E. Chmielnicki, A. Benraiss, A. N. Economides, and S. A. Goldman (2004)
J. Neurosci.
24, 2133-2142
|Abstract »|Full Text »|PDF »
Domain-specific Modification of Heparan Sulfate by Qsulf1 Modulates the Binding of the Bone Morphogenetic Protein Antagonist Noggin.
B. L. Viviano, S. Paine-Saunders, N. Gasiunas, J. Gallagher, and S. Saunders (2004)
J. Biol. Chem.
279, 5604-5611
|Abstract »|Full Text »|PDF »
Perlecan, the Multidomain Heparan Sulfate Proteoglycan of Basement Membranes, Is also a Prominent Component of the Cartilaginous Primordia in the Developing Human Fetal Spine.
J. Melrose, S. Smith, P. Ghosh, and J. Whitelock (2003)
Journal of Histochemistry & Cytochemistry
51, 1331-1341
|Abstract »|Full Text »|PDF »
Dally regulates Dpp morphogen gradient formation in the Drosophila wing.
M. Fujise, S. Takeo, K. Kamimura, T. Matsuo, T. Aigaki, S. Izumi, and H. Nakato (2003)
Development
130, 1515-1522
|Abstract »|Full Text »|PDF »
A Novel Vascular Endothelial Growth Factor Heparin-binding Domain Substructure Binds to Glycosaminoglycans in Vivo and Localizes to Tumor Microvascular Endothelium.
A. El-Sheikh, C. Liu, H. Huang, and T. S. Edgington (2002)
Cancer Res.
62, 7118-7123
|Abstract »|Full Text »|PDF »